Latest news with #Desmarais
Yahoo
9 hours ago
- Business
- Yahoo
SEED Therapeutics Appoints Dr. Bill Desmarais as Chief Financial Officer and Chief Business Officer
KING OF PRUSSIA, Pa., June 09, 2025 (GLOBE NEWSWIRE) -- SEED Therapeutics Inc. ("SEED"), a biotechnology company pioneering targeted protein degradation (TPD) through the discovery of innovative molecular glues and bifunctional degraders, today announced the appointment of Dr. Bill Desmarais, Ph.D., MBA, as Chief Financial Officer and Chief Business Officer. "Bill's appointment comes at a pivotal time as SEED advances its differentiated pipeline into clinical trials and expands global strategic partnerships,' said Dr. Lan Huang, Co-Founder, Chairman, and CEO of SEED. 'His extensive experience in high-impact transactions and strategic licensing will strengthen SEED's ability to accelerate breakthrough therapies in oncology, neurodegeneration, and immunology through our proprietary RITE3™ TPD platform. This appointment underscores SEED's commitment to delivering transformative treatments for patients, partners, and shareholders in 2025 and beyond.' Dr. Desmarais brings more than two decades of leadership in finance, business development, and strategic operations within the biopharma and biotech industries. He previously served as Chief Business Officer at Alchemab Therapeutics and TScan Therapeutics, as well as Vice President of Business Development at Momenta Pharmaceuticals, where he played a critical role in the company's $6.5 billion acquisition by Johnson & Johnson. Earlier in his career, he spent over a decade at Eli Lilly and Company in Search & Evaluation and Corporate Business Development, advancing global partnerships and pipeline expansion. Dr. Desmarais holds a Ph.D. in Biophysics and Structural Biology from Brandeis University, an MBA from the MIT Sloan School of Management, and a B.S. in Biology from Purdue University. "I am excited to join SEED at this transformative moment, working alongside an exceptional team of leaders and innovators,' said Dr. Desmarais. 'I look forward to collaborating with Dr. Lan Huang and her distinguished SEED Co-Founders—Nobel Laureate Avram Hershko and HHMI Investigators Michele Pagano and Ning Zheng—who are at the forefront of breakthrough research in targeted protein degradation. SEED's world-class translational scientists, drug developers, and deeply engaged Board of Directors bring unparalleled expertise across science, finance, risk management, law, and governance. Together, we will advance SEED's groundbreaking strategy, forge key alliances, and drive meaningful impact for patients and stakeholders worldwide.' About SEED TherapeuticsSEED Therapeutics is a biotechnology company dedicated to advancing targeted protein degradation (TPD) through the discovery of novel molecular glues and bifunctional degraders. Powered by its proprietary RITE3™ TPD platform, SEED is developing a pipeline of first-in-class degraders aimed at traditionally undruggable targets across oncology, neurodegeneration, immunology, and virology. Strategic collaborations with industry leaders Eli Lilly and Company and Eisai Co., Ltd. further reinforce SEED's commitment to developing innovative therapies, with its lead RBM39 degrader program expected to enter clinical trials in 2025. For more information, visit Investor Contact: IR@ Contact: PR@
Yahoo
9 hours ago
- Business
- Yahoo
SEED Therapeutics Appoints Dr. Bill Desmarais as Chief Financial Officer and Chief Business Officer
KING OF PRUSSIA, Pa., June 09, 2025 (GLOBE NEWSWIRE) -- SEED Therapeutics Inc. ("SEED"), a biotechnology company pioneering targeted protein degradation (TPD) through the discovery of innovative molecular glues and bifunctional degraders, today announced the appointment of Dr. Bill Desmarais, Ph.D., MBA, as Chief Financial Officer and Chief Business Officer. "Bill's appointment comes at a pivotal time as SEED advances its differentiated pipeline into clinical trials and expands global strategic partnerships,' said Dr. Lan Huang, Co-Founder, Chairman, and CEO of SEED. 'His extensive experience in high-impact transactions and strategic licensing will strengthen SEED's ability to accelerate breakthrough therapies in oncology, neurodegeneration, and immunology through our proprietary RITE3™ TPD platform. This appointment underscores SEED's commitment to delivering transformative treatments for patients, partners, and shareholders in 2025 and beyond.' Dr. Desmarais brings more than two decades of leadership in finance, business development, and strategic operations within the biopharma and biotech industries. He previously served as Chief Business Officer at Alchemab Therapeutics and TScan Therapeutics, as well as Vice President of Business Development at Momenta Pharmaceuticals, where he played a critical role in the company's $6.5 billion acquisition by Johnson & Johnson. Earlier in his career, he spent over a decade at Eli Lilly and Company in Search & Evaluation and Corporate Business Development, advancing global partnerships and pipeline expansion. Dr. Desmarais holds a Ph.D. in Biophysics and Structural Biology from Brandeis University, an MBA from the MIT Sloan School of Management, and a B.S. in Biology from Purdue University. "I am excited to join SEED at this transformative moment, working alongside an exceptional team of leaders and innovators,' said Dr. Desmarais. 'I look forward to collaborating with Dr. Lan Huang and her distinguished SEED Co-Founders—Nobel Laureate Avram Hershko and HHMI Investigators Michele Pagano and Ning Zheng—who are at the forefront of breakthrough research in targeted protein degradation. SEED's world-class translational scientists, drug developers, and deeply engaged Board of Directors bring unparalleled expertise across science, finance, risk management, law, and governance. Together, we will advance SEED's groundbreaking strategy, forge key alliances, and drive meaningful impact for patients and stakeholders worldwide.' About SEED TherapeuticsSEED Therapeutics is a biotechnology company dedicated to advancing targeted protein degradation (TPD) through the discovery of novel molecular glues and bifunctional degraders. Powered by its proprietary RITE3™ TPD platform, SEED is developing a pipeline of first-in-class degraders aimed at traditionally undruggable targets across oncology, neurodegeneration, immunology, and virology. Strategic collaborations with industry leaders Eli Lilly and Company and Eisai Co., Ltd. further reinforce SEED's commitment to developing innovative therapies, with its lead RBM39 degrader program expected to enter clinical trials in 2025. For more information, visit Investor Contact: IR@ Contact: PR@ in to access your portfolio
Yahoo
12-03-2025
- General
- Yahoo
Veteran at beach to spread dog's ashes is crushed by log from sneaker wave in Oregon
Julian Desmarais was at an Oregon beach to spread his dog's ashes when an unexpected wave came crashing onto the shoreline. That wave threw Desmarais, an Army veteran, off the log he was standing on. The log then crushed him and broke his leg, a TikTok video shows. Desmarais and his friend Emmy Isle went to a beach March 1 near Mo's Seafood & Chowder in Lincoln City, he told McClatchy News by phone on March 12. He was there to spread Koda's ashes, a King German Shepherd and Desmarais' companion for the past nine years. 'He was a water dog, and the beach was one of his favorite places. That's why I was going out there,' he said. Desmarais went close to the shoreline, stood on a log and started to pull out Koda's ashes when a sneaker wave came out of nowhere and sent him into the water. Isle was standing further from the water and caught the moment on camera. A video shows Desmarais fall forward as the wave hits, then he falls backward as the log rolls over him. Isle stops recording to rush over to help her friend. At this point, Desmarais said he started crawling and was 'screaming for help.' Onlookers also heard his cries and ran over to him, including an off-duty medic, he said. It took about five or six people to carry him to a waiting ambulance where he was taken to a nearby hospital in Lincoln City. Desmarais then had to be transported to a different hospital in Corvallis where he underwent surgery for a broken femur. 'It was the most pain I've ever been in in my life, hands down,' he said. Cody Heidt, a spokesperson for the North Lincoln Fire & Rescue District #1, told McClatchy News the log weighed about two tons. The average weight of a white rhino is about the same. Although, Desmarais grew up in the area, he said he knew better and shouldn't have been standing on the log to begin with. 'I'm just happy to be alive. I'm very, very lucky.' Sneaker waves unexpectedly surge up further on the beach. They can be deadly and dangerous, according to the National Oceanic and Atmospheric Administration. These waves can sweep beachgoers away, and they can carry heavy wet pieces of logs that can knock people over or pin them. Beachgoers should check weather, surf and tide forecasts for any warnings of sneaker waves, NOAA said. 'We would like to remind beachgoers to not stand or play on drift wood/logs that are near the surf line, never turn their backs on the ocean, and to watch for and adhere to warning signs that are posted,' Heidt said in an e-mail. Lincoln City is about a 60-mile drive west from Salem. Man rushes to save 8-year-old boy swept to sea, but both die, California officials say Rescuers rush to help dad and teen after finding them trapped on rocks at Oregon beach Two die after wave sweeps them off rocks and out to sea, California rescuers say
Yahoo
25-02-2025
- Sport
- Yahoo
Hometown Hero – Gianna Desmarais, Cranston West
CRANSTON, RI (WPRI) — This week's Cardi's Furniture & Mattresses Hometown Sports Hero is Gianna Desmarais. The Cranston West Sophomore won gold in the Vault and Bars at the State Gymnastics Meet and her overall score of 37.2 was enough to best the defending champion, LaSalle Senior Lauren Horrigan, for the All-Around Title. Desmarais win made her only the second Falcon to win the Individual Crown. 'It was an amazing experience,' Desmarais said. 'I wasn't expecting it at first, but I came into the competition with confidence and yes, just an amazing experience.' 'We were surprised but we knew she had it in her,' said Falcon Head Coach Tanya Forti. 'And she could definitely do it based on Saturday's Meet and how well she did. And I knew she was in such a great head space, that she was ready, focused and prepared.' She started in Gymnastics at a young age and her growth in the sport helping her focus. 'When I was three years old, I was climbing out of my crib, so my parents thought it was a good idea to put me in Gymnastics Class and ever since then, I've been with Dream Big since 3 years old.' 'Honestly, everything. I just love the sport in general and it helps me push to be a better person.' Gianna will look to add another crown in two weeks when she competes at New England's. Then she will jump into her club season with her Dream Big Gymnastics team. Success in States and Regionals could earn her a trip to Nationals and she's hoping her efforts will one day earn her a Division I college scholarship. 'Honestly I think I can push myself a little bit harder to become a better Gymnast and eventually bring myself to the point where I can be a Division I athlete,' Desmarais said. 'She's going to be incredible,' Forti said. 'She's definitely going to be the player to watch for sure. She's only a Sophomore and already doing this well, the next two years are going to be incredible for her.' If you have a Hometown Sports Hero you'd like to nominate, email sports@ Close Thanks for signing up! Watch for us in your inbox. Subscribe Now Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
